Uihlein Richard E.'s most recent trade in Galectin Therapeutics Inc was a trade of 60,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.23 per share. | 23 Jan 2025 | 32,520 | 10,301,271 (18%) | 0% | 1.2 | 40,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Uihlein Richard E. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.72 per share. | 24 Jan 2024 | 23,256 | 10,268,751 (18%) | 0% | 1.7 | 40,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 26 Sep 2023 | 1,466,204 | 9,466,495 (16%) | 2% | 5 | 7,331,020 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2023 | 1,466,204 | 0 | - | - | Common Stock Purchase Warrant (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2023 | 200,000 | 0 | - | - | Common Stock Purchase Warrant (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2023 | 200,000 | 0 | - | - | Common Stock Purchase Warrant (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2023 | 200,000 | 0 | - | - | Common Stock Purchase Warrant (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 26 Sep 2023 | 200,000 | 10,235,495 (17%) | 0% | 3 | 600,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.26 per share. | 26 Sep 2023 | 200,000 | 10,035,495 (17%) | 0% | 3.3 | 652,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 26 Sep 2023 | 200,000 | 9,835,495 (17%) | 0% | 3 | 600,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. | 26 Sep 2023 | 170,000 | 9,635,495 (16%) | 0% | 5 | 850,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2023 | 170,000 | 330,000 | - | - | Common Stock Purchase Warrant (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.11 per share. | 26 Jan 2023 | 36,036 | 7,999,291 (14%) | 0% | 1.1 | 40,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.98 per share. | 24 Jan 2022 | 17,677 | 7,936,677 (13%) | 0% | 2.0 | 35,000 | Common Stock |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2021 | 1,157,407 | 10,000,000 | - | - | Convertible Note | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2021 | 2,000,000 | 10,000,000 | - | - | Convertible Note | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 40,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Richard E. Uihlein | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.55 per share. | 04 Sep 2020 | 10,000 | 7,893,191 (13%) | 0% | 2.6 | 25,500 | Common Stock |